Company Overview
Astrotech Corporation functions as a mass spectrometry entity operating on a global scale, where it owns and licenses intellectual property associated with its platform mass spectrometry technology while also developing the TRACER 1000, a mass spectrometer-based explosive trace detector. The company operates within the Technology sector, specifically classified under the Scientific & Technical Instruments industry, positioning it to serve specialized markets requiring high-precision analytical equipment. In terms of scale, Astrotech reports a market capitalization of $4.17M, generates annual revenue of $1.20M, and maintains an employee base of 32 individuals. These figures indicate that the company functions as a micro-cap enterprise with a relatively small revenue footprint, suggesting a niche operational model that relies heavily on intellectual property leverage rather than broad market volume to sustain its business activities.
Financial Health
The company reports a Trailing Twelve Months (TTM) revenue of $1.20M, yet it simultaneously records a net income loss of $-13,955,000 and an EBITDA figure of $-13,274,000. The substantial gap between the $1.20M revenue and the $-13,955,000 net income reveals a highly volatile cost structure where operating expenses significantly outweigh total revenue, resulting in a loss that is more than ten times the size of the company's annual sales. Regarding financial flexibility, the free cash flow stands at $-9,568,750, indicating that the company is burning cash rapidly and lacks the internal liquidity to fund operations or growth without external capital injection. When analyzing profitability metrics, the gross margin is 42.3%, which suggests that the cost of goods sold is well-controlled relative to sales; however, the operating margin is -2635.8% and the profit margin is 0.0%, highlighting severe overhead inefficiencies that destroy value before reaching the bottom line. The balance sheet shows a cash position of $10.13M against total debt of $2.45M, resulting in a debt-to-equity ratio of 15.80, which implies a conservative leverage structure regarding debt obligations but indicates potential equity erosion. The current ratio is 7.56, a metric that signifies strong short-term liquidity, as current assets are more than seven times the value of current liabilities, providing a significant buffer against immediate payment obligations. Furthermore, the return on equity is -64.0% and the return on assets is -35.1%, metrics that reveal that management has not yet generated positive returns on the capital invested by shareholders or utilized in the asset base, reflecting the current stage of the company's financial development.
Valuation Assessment
The valuation metrics present a complex picture, with a P/E Ratio (TTM) listed as N/A due to the lack of positive earnings, while the Forward P/E is reported at -3.49. The discrepancy between a missing trailing multiple and a negative forward multiple implies that the market expects earnings to remain negative in the near term, rendering traditional earnings-based valuation models inapplicable until profitability is restored. The price-to-book ratio stands at 0.26, indicating that the stock trades at a significant discount to its book value, suggesting that the market prices the company well below the replacement cost of its tangible assets. Alternative valuation metrics provide further context, with a price-to-sales ratio of 3.48 and an EV/EBITDA of 0.28; these figures suggest that despite the negative earnings, the market assigns a premium relative to sales, though the negative EV/EBITDA reinforces the earnings deficit. Price action data shows a 52-week high of $8.01 and a 52-week low of $1.92, and assuming the current price sits within this range, the stock is trading at a level that reflects significant downside from its recent peak while remaining above its absolute low. The beta value is 0.37, which indicates that the stock exhibits low price volatility relative to the broader market, moving with less intensity than the overall index and potentially offering a different risk profile for risk-averse portfolios.
Growth & Income
The growth profile is characterized by a revenue growth rate of -43.3% year-over-year, while earnings growth is listed as N/A due to the absence of prior period earnings for comparison. The decline in revenue by 43.3% implies a contraction in market share or product demand, and since earnings are negative, there is no positive earnings growth to offset the revenue decline. Regarding income distribution, the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning that any potential earnings are retained for reinvestment rather than distributed to shareholders. Consequently, the overall growth and income profile for Astrotech Corporation is defined by negative revenue expansion and a complete lack of current income generation, requiring external capital sources to fund operations and future product development initiatives.